No Data
No Data
Express News | JW (Cayman) Therapeutics - Pwc Has Tendered Resignation to Board as Auditor
JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Stock Rockets 31% But Many Are Still Ignoring The Company
JW THERAP-B: 2024 INTERIM REPORT
Pharmaron -B (02126) fell 42.80%, now at 1.300 yuan, hitting a 52-week low.
As of 11:34, Wuxi Apptec -B (02126) fell by 42.80% from the previous closing price to 1.300 yuan, hitting a 52-week low; the volume was 0.0227 million shares, with a turnover of 0.0294 million Hong Kong dollars.
WuXi AppTec-B (02126) granted a total of 2.0391 million share purchase rights and a total of 0.6696 million restricted share units.
WuXi AppTec-B (02126) announced in a notice that on September 2, 2024, in accordance with October 14, 2020...
WuXi Biologics-B (02126) appointed Chen Bingjun as an independent non-executive director.
Pharmaron-B (02126) announced that Chen Bingjun has been appointed as an independent non-executive director, effective from August 2, 2024...
No Data